Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Coronavirus Disease (COVID-19) Control between Drug Repurposing and Vaccination: A Comprehensive Overview
Ahmed A. Al‐Karmalawy, Raya Soltane, Ayman Abo Elmaaty, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1317-1317
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Molnupiravir: A lethal mutagenic drug against rapidly mutating severe acute respiratory syndrome coronavirus 2—A narrative review
Sri Masyeni, Muhammad Iqhrammullah, Andri Frediansyah, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 7, pp. 3006-3016
Open Access | Times Cited: 62
In vitro and computational insights revealing the potential inhibitory effect of Tanshinone IIA against influenza A virus
Dalia Elebeedy, Ingy Badawy, Ayman Abo Elmaaty, et al.
Computers in Biology and Medicine (2021) Vol. 141, pp. 105149-105149
Closed Access | Times Cited: 54
Newly synthesized series of oxoindole–oxadiazole conjugates as potential anti-SARS-CoV-2 agents:in silicoandin vitrostudies
Rana M. El-Masry, Ahmed A. Al‐Karmalawy, Radwan Alnajjar, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 11, pp. 5078-5090
Closed Access | Times Cited: 54
A Systematic Review of the Global Intervention for SARS-CoV-2 Combating: From Drugs Repurposing to Molnupiravir Approval
Nada A. Ashour, Ayman Abo Elmaaty, Amany A. Sarhan, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 685-715
Open Access | Times Cited: 40
Anticoagulants as Potential SARS-CoV-2 Mpro Inhibitors for COVID-19 Patients: In Vitro, Molecular Docking, Molecular Dynamics, DFT, and SAR Studies
Ayman Abo Elmaaty, Wagdy M. Eldehna, Muhammad Khattab, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12235-12235
Open Access | Times Cited: 39
Bioactive Azadirachta indica and Melia azedarach leaves extracts with anti-SARS-CoV-2 and antibacterial activities
Bahaa A. Hemdan, Ahmed Mostafa, Marwa M. Elbatanony, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0282729-e0282729
Open Access | Times Cited: 24
Identification of Natural Lead Compounds against Hemagglutinin-Esterase Surface Glycoprotein in Human Coronaviruses Investigated via MD Simulation, Principal Component Analysis, Cross-Correlation, H-Bond Plot and MMGBSA
Iqra Ali, Muhammad Asif Rasheed, Simona Cavalu, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 793-793
Open Access | Times Cited: 19
Zoonosis and zooanthroponosis of emerging respiratory viruses
Ahmed Magdy Khalil, Luis Martínez‐Sobrido, Ahmed Mostafa
Frontiers in Cellular and Infection Microbiology (2024) Vol. 13
Open Access | Times Cited: 6
Ligand-based design, synthesis, computational insights, andin vitrostudies of novelN-(5-Nitrothiazol-2-yl)-carboxamido derivatives as potent inhibitors of SARS-CoV-2 main protease
Mohamed Elagawany, Ayman Abo Elmaaty, Ahmed Mostafa, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2112-2132
Open Access | Times Cited: 34
Investigating the possible mechanisms of pirfenidone to be targeted as a promising anti-inflammatory, anti-fibrotic, anti-oxidant, anti-apoptotic, anti-tumor, and/or anti-SARS-CoV-2
Samar A. Antar, Mohamed A. Saleh, Ahmed A. Al‐Karmalawy
Life Sciences (2022) Vol. 309, pp. 121048-121048
Open Access | Times Cited: 30
Phytoestrogen β-Sitosterol Exhibits Potent In Vitro Antiviral Activity against Influenza A Viruses
Sara Shokry, Akram Hegazy, Ahmad M. Abbas, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 228-228
Open Access | Times Cited: 18
Investigating the potential anticancer activities of antibiotics as topoisomerase II inhibitors and DNA intercalators: in vitro , molecular docking, molecular dynamics, and SAR studies
Faten Farouk, Ayman Abo Elmaaty, Ahmed Elkamhawy, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 18
The Breadth of Bacteriophages Contributing to the Development of the Phage-Based Vaccines for COVID-19: An Ideal Platform to Design the Multiplex Vaccine
Ihtisham Ul Haq, Katarzyna Krukiewicz, Galal Yahya, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1536-1536
Open Access | Times Cited: 14
Lessons we learned during the past four challenging years in the COVID-19 era: pharmacotherapy, long COVID complications, and vaccine development
Parisa Ghasemiyeh, Soliman Mohammadi‐Samani
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Antiviral responses versus virus-induced cellular shutoff: a game of thrones between influenza A virus NS1 and SARS-CoV-2 Nsp1
Ahmed Magdy Khalil, Aitor Nogales, Luis Martínez‐Sobrido, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 4
What’s new in flow biocatalysis? A snapshot of 2020–2022
Michele Crotti, Marina Simona Robescu, Juan M. Bolívar, et al.
Frontiers in Catalysis (2023) Vol. 3
Open Access | Times Cited: 10
MasitinibL shows promise as a drug-like analog of masitinib that elicits comparable SARS-Cov-2 3CLpro inhibition with low kinase preference
Olanrewaju Ayodeji Durojaye, Nkwachukwu Oziamara Okoro, Arome Solomon Odiba, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Theoretical effectiveness of steam inhalation against SARS-CoV-2 infection: updates on clinical trials, mechanism of actions, and traditional approaches
Md. Nafees Rahman Chowdhury, Yasin Arafat Alif, Safaet Alam, et al.
Heliyon (2022) Vol. 8, Iss. 1, pp. e08816-e08816
Open Access | Times Cited: 17
Optical, Structural, Electrical Characterization of (Polyvinyl Alcohol–Carboxymethyl Cellulose-Manganese Dioxide) Nanocomposite Fabricated via Laser Ablation
Rami Adel Pashameah, Mohamed El-Sharnouby, Ahmad El-Askary, et al.
Journal of Inorganic and Organometallic Polymers and Materials (2022) Vol. 32, Iss. 8, pp. 2863-2872
Closed Access | Times Cited: 16
Synthesis of Potential Antiviral Agents for SARS-CoV-2 Using Molecular Hybridization Approach
Kailey A. Wyman, Adel S. Girgis, Pragnakiran S. Surapaneni, et al.
Molecules (2022) Vol. 27, Iss. 18, pp. 5923-5923
Open Access | Times Cited: 15
Molecular Understanding of ACE-2 and HLA-Conferred Differential Susceptibility to COVID-19: Host-Directed Insights Opening New Windows in COVID-19 Therapeutics
Ihtisham Ul Haq, Katarzyna Krukiewicz, Hamnah Tayyab, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 7, pp. 2645-2645
Open Access | Times Cited: 8
Design, Synthesis and In Vitro Evaluation of Spirooxindole-Based Phenylsulfonyl Moiety as a Candidate Anti-SAR-CoV-2 and MERS-CoV-2 with the Implementation of Combination Studies
Assem Barakat, Ahmed Mostafa, M. Ali, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11861-11861
Open Access | Times Cited: 14
Investigating the Potential Anti-SARS-CoV-2 and Anti-MERS-CoV Activities of Yellow Necklacepod among Three Selected Medicinal Plants: Extraction, Isolation, Identification, In Vitro, Modes of Action, and Molecular Docking Studies
Howaida I. Abd‐Alla, Omnia Kutkat, Heba-tollah M. Sweelam, et al.
Metabolites (2022) Vol. 12, Iss. 11, pp. 1109-1109
Open Access | Times Cited: 12
Antiviral effects of Atractyloside A on the influenza B virus (Victoria strain) infection
Jicheng Han, Xiangyu Zhu, Zihan Gao, et al.
Frontiers in Microbiology (2023) Vol. 13
Open Access | Times Cited: 5
Investigating the promising SARS-CoV-2 main protease inhibitory activity of secoiridoids isolated from Jasminum humile ; in silico and in Vitro assessments with structure-activity relationship
Ahmed A. Al‐Karmalawy, Radwan Alnajjar, Ayman Abo Elmaaty, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 13, pp. 6941-6953
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top